609
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

Randomized open-label trial of baclofen for relapse prevention in alcohol dependence

, MBBS, MD, , MBBS, MD, , MBBS, DPM, , MBBS, DNB & , MBBS, MD
Pages 324-331 | Received 27 May 2015, Accepted 21 Sep 2016, Published online: 03 Nov 2016

References

  • Edwards G, Gross MM. Alcohol dependence: provisional description of a clinical syndrome. Br Med J 1976;1:1058–1061.
  • WHO Global status report on alcohol and health 2014. Available at: http://www.who.int/substance_abuse/publications/global_alcohol_report/msb_gsr_2014_2.pdf?ua=1 [last accessed 21 July 2016]
  • Rehm J. The risks associated with alcohol use and alcoholism. Alcohol Res Health 2011;34:135–143.
  • UNODC. National Survey on Extent, Pattern and Trends of Drug Abuse in India. New Delhi, 2004. Available from: http://www.unodc.org/pdf/india/presentations/india_national_survey_2004.pdf [last accessed 20 July 2016]
  • Miller WR, Hester RK. Inpatient alcoholism treatment: who benefits? Am Psychol 1986;41:794–805.
  • Krishnan-Sarin S, O’Malley S, Krystal JH. Treatment implications: using neuroscience to guide the development of new pharmacotherapies for alcoholism. Alcohol Res Health 2008;31:400–407.
  • Fuller RK, Branchey L, Brightwell DR et al. Disulfiram treatment of alcoholism: a Veterans Administration cooperative study. JAMA1986;256:1449–1455.
  • Bouza C, Angeles M, Muñoz A, Amate JM. Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction 2004;99:811–828.
  • Mann K, Lehert P, Morgan MY. The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis. Alcohol Clin Exp Res 2004;28:51–63.
  • Addolorato G, Abenavoli L, Leggio L et al. How many cravings? Pharmacological aspects of craving treatment in alcohol addiction: a review. Neuropsychobiology 2005;51:59–61.
  • Colombo G, Addolorato G, Agabio R et al. Role of GABA (B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics. Neurotox Res 2004;6:403–414.
  • Baclofen: Drug information. In: UpToDate.DS Basow, ed. UpToDate Waltham, MA, 2010.
  • Addolorato G, Caputo F, Capristo et al. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomised controlled study. Alcohol 2002;37:504–508.
  • Flannery BA, Garbutt JC, Cody MW et al. Baclofen for alcohol dependence: a preliminary open-label study. Alcohol Clin Exp Res 2004;28:1517–1523.
  • Garbutt JC, Kampov-Polevoy AB, Gallop R et al. Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcohol Clin Exp Res 2010;34:1849–1857.
  • World Health Organization. International statistical classification of diseases and related health problems, 10th Revision (ICD-10). Geneva: WHO, 1992.
  • Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin Psychiatry 1998;59(suppl 20):22–33.
  • Anton RF, Moak DH, Latham PK. The obsessive compulsive drinking scale: a new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry1996;53:225–231.
  • Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50–55.
  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.AddoloratoG, Leggio L, Ferrulli A et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent participants with liver cirrhosis: randomised, double-blind controlled study. Lancet 2007;370:1915–1922.
  • Cutler RB, Fishbain DA. Are alcoholism treatments effective? The Project MATCH data. BMC Public Health 2005;5:75.
  • Drake RG, Davis LL, Cates ME et al. Baclofen treatment for chronic posttraumatic stress disorder. Ann Pharmacother 2003;37:1177–1181.
  • Manteghi AA, Hebrani P, Mortezania M et al. Baclofen add-on to citalopram in treatment of posttraumatic stress disorder. J Clin Psychopharmacol 2014;34:240–243.
  • WR Miller,Sanchez, VC. Motivating young adults for treatment and lifestyle change. In: Howard, G, ed. Issues in alcohol use and misuse by young adults. Notre Dame, IN: University of Notre Dame Press; 1993
  • Schulz KF, Altman DG, D. Moher CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J Pharma Pharmacoth 2010;1:100–107.
  • Driessen M, Meier S, Hill A et al. The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol 2001;36:249–255.
  • Agabio R, Colombo G. GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence. Front Neurosci 2014;8:140.
  • Anton RF, O’Malley SS, Ciraulo DA et al. COMBINE Study Research Group. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 2006;295:2003–2017.
  • Krystal JH, Cramer JA, Krol WF et al. Veterans Affairs Naltrexone Cooperative Study 425 Group. Naltrexone in the treatment of alcohol dependence. N Engl J Med 2001;345:1734–1739.
  • Addolorato G, Leggio L, Abenavoli L et al. Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med 2006;119:276.e13–e18.
  • Ponizovsky AM, Rosca P, Aronovich E et al. Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up. J Subst Abuse Treat 2015;52:24–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.